Step Rate in Recreational Runners

November 9, 2018 updated by: Jonathan T. Finnoff, Mayo Clinic

The Effect of a Home Training Program on Preferred Step Rate in Recreational Runners

This will be a pilot study to determine if a 6 week home training program can increase preferred step rate (cadence) in recreational runners. Increase in step rate has been correlated with decreased stress at lower limb joints in runners. This has the potential of decreasing overuse injuries in this population.

Research participants will have their preferred cadence evaluated at the beginning of the study. The athletes will be randomly assigned to two groups. One group will continue to train without intervention and the other group will train at a cadence of 10% higher than their preferred step rate.

At the end of 6 weeks the participants will have their preferred cadence reevaluated using the same method as pre-participation cadence was determined.

The investigators hypothesis the preferred running cadence of recreational runners following the intervention will be 5-10% greater than prior to the intervention and the increased cadence will be maintained for 6 months following the intervention.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Minnesota
      • Rochester, Minnesota, United States, 55905
        • Mayo Clinic in Rochester

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion criteria:

  • healthy male or female runners
  • 18 years of age or greater
  • run two or more times per week most weeks of the year for at least 4 years
  • cadence of 85 strides/min or less as determined at initial evaluation
  • no musculoskeletal injuries or illnesses that would limit running in the last 6 months
  • currently running at least 15 miles a week

Exclusion criteria:

  • baseline running cadence greater than 85 strides/min
  • inability to run
  • cardiovascular disease
  • greater than 2 cardiovascular risk factors
  • peripheral vascular disease
  • neurological disease
  • musculoskeletal injury or disease that causes pain with running

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
This group will undergo home exercise program designed to increase their running cadence.
Behavioral: Change in running cadence
The intervention will involve a home exercise program designed to increase the running cadence in recreational runners.
No Intervention: Control Group
This group will not receive any intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Running cadence
Time Frame: 6 weeks
Running cadence (steps per minute) will be evaluated using a running cadence sensor to determine if the intervention subjects increased their running cadence by 10 steps per minute following the intervention.
6 weeks
Running cadence
Time Frame: 6 months
Running cadence (steps per minute) will be evaluated using a running cadence sensor to determine if the intervention subjects maintained their increased running cadence for 6 months following the intervention.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Mayo Clinic

Investigators

  • Principal Investigator: Jonathan T Finnoff, Mayo Clinic

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2017

Primary Completion (Actual)

June 1, 2018

Study Completion (Actual)

June 1, 2018

Study Registration Dates

First Submitted

February 14, 2017

First Submitted That Met QC Criteria

February 15, 2017

First Posted (Actual)

February 20, 2017

Study Record Updates

Last Update Posted (Actual)

November 14, 2018

Last Update Submitted That Met QC Criteria

November 9, 2018

Last Verified

November 1, 2018

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 16-008532

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No IPD will be shared with other researchers

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe